Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
58 hedge funds and large institutions have $333M invested in Amryt Pharma plc American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 8 closing their positions.
114% more call options, than puts
Call options by funds: $30K | Put options by funds: $14K
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
5% more capital invested
Capital invested by funds: $316M → $333M (+$16.9M)
6% less funds holding
Funds holding: 62 → 58 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$744K |
| 2 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$705K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$446K |
| 4 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$290K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$219K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.07M |
| 2 |
Millennium Management
New York
|
-$852K |
| 3 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$277K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$168K |
| 5 |
D.E. Shaw & Co
New York
|
-$155K |
AMYT Hedge Fund Activity: Q4 2022 in Review
58 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q4 2022, worth a combined $333M — up 5.3% from $316M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of AMYT and 4 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 12 added.
The largest buyer was Stonepine Capital Management, adding an estimated $744K. The largest seller was Armistice Capital, cutting an estimated $2.07M.
- 58 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q4 2022, down from 62 in Q3 2022.
- Funds reported $333M of Amryt Pharma plc American Depositary Shares stock for Q4 2022, up 5.3% quarter-over-quarter.
- 4 funds opened new Amryt Pharma plc American Depositary Shares positions in Q4 2022 and 8 closed out, a net change of -4 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q4 2022 was Stonepine Capital Management, an estimated $744K added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q4 2022 was Armistice Capital, an estimated $2.07M sold.
Based on aggregated 13F filings for Q4 2022.